Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Health In Tech, Inc. filings on SEC EDGAR ↗
For the nine months ended September 30, 2026, Health In Tech, Inc. reported total revenues of $23.4 million, a decrease from $25.8 million in the prior year period. The company experienced a significant shift in its financial position, moving from a retained earnings balance of $5.2 million at the end of 2025 to an accumulated deficit of $5.9 million as of September 30, 2026.
Health In Tech reported Q3 2026 revenue of $6.6 million and a net loss of $7.1 million, which included a $5.3 million provision for credit losses. The company highlighted a 15.9% year-over-year growth in distribution partners and a revenue pipeline of $156.4 million as of late October.
Term
Q3 2026
“It is a privilege to lead Health In Tech into its next chapter, and I want to thank Tim Johnson, our founder and Executive Chairman, and the Board for their confidence. Throughout my career, I have focused on scaling businesses, developing growth strategies, and leveraging capital markets to support long-term value creation. I have substantial operational experience scaling new products from incubation to meaningful commercial scale, building”
Sanjay Shrestha, Chief Executive Officer of Health In Tech